Skip to main content

Advertisement

Log in

Structural and functional brain changes in hepatic and neurological Wilson disease

  • Original Research
  • Published:
Brain Imaging and Behavior Aims and scope Submit manuscript

Abstract

Wilson disease (WD) can manifest with hepatic or neuropsychiatric symptoms. Our understanding of the in vivo brain changes in WD, particularly in the hepatic phenotype, is limited. Thirty subjects with WD and 30 age- and gender-matched controls participated. WD group underwent neuropsychiatric assessment. Unified WD Rating Scale neurological exam scores were used to determine neurological (WDN, score > 0) and hepatic-only (WDH, score 0) subgroups. All subjects underwent 3 Tesla anatomical and resting-state functional MRI. Diffusion tensor imaging (DTI) and susceptibility-weighted imaging (SWI) were performed only in the WD group. Volumetric, DTI, and functional connectivity analyses were performed to determine between-group differences. WDN and WDH groups were matched in demographic and psychiatric profiles. The entire WD group compared to controls showed significant thinning in the bilateral superior frontal cortex. The WDN group compared to control and WDH groups showed prominent structural brain changes including significant striatal and thalamic atrophy, more subcortical hypointense lesions on SWI, and diminished white matter integrity in the bilateral anterior corona radiata and corpus callosum. However, the WDH group also showed significant white matter volume loss compared to controls. The functional connectivity between the frontostriatal nodes was significantly reduced in the WDN group, whereas that of the hippocampus was significantly increased in the WDH group compared to controls. In summary, structural and functional brain changes were present even in neurologically non-manifesting WD patients in this cross-sectional study. Longitudinal brain MRI scans may be useful as biomarkers for prognostication and optimization of treatment strategies in WD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Download references

Acknowledgments

We thank the Wilson Disease Association for their help with participant recruitment.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Funding

This study was supported through the grants from the Jack Levin Foundation, The Rachel and Drew Katz Foundation and the Albert Family to the Yale University School of Medicine.

Author information

Authors and Affiliations

Authors

Contributions

Study conceptualization and design: ST, DR, MLS, RTC. Data collection: KN, AVR, JA. Data analysis and interpretation: ST, JA, KN, AVR, MS, AP, RTC. Supervision of the study procedures: ST, DR, RTC, MLS. Drafting the manuscript: ST. All authors contributed to the final version of the manuscript.

Corresponding author

Correspondence to Sule Tinaz.

Ethics declarations

Conflict of interest

Authors Tinaz, Arora, Nalamada, Vives-Rodriguez, Sezgin, Robakis, Patel, and Constable declare that they have no conflict of interest. Author Schilsky received grant funding from Alexion and GMPO.

Ethical approval

All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from all participants included in the study.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(PDF 457 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tinaz, S., Arora, J., Nalamada, K. et al. Structural and functional brain changes in hepatic and neurological Wilson disease. Brain Imaging and Behavior 15, 2269–2282 (2021). https://doi.org/10.1007/s11682-020-00420-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11682-020-00420-5

Keywords

Navigation